Orphenadrine Citrate
Product Images NDC 10544-283

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Orphenadrine Citrate (NDC 10544-283). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Blenheim Pharmacal, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (4ed1b591 Figure 01)

Chemical structure of Orphenadrine Citrate, showing the molecular arrangement of the pharmaceutical compound as two distinct chemical entities representing orphenadrine and citrate components.*

FDA Label Image

100mg 20ct (Label Orphenadrine Citrate Extended Release Tabs 100mg Bpi(10544 283 20))

Label for Orphenadrine Citrate Extended-Release Tablets, 100 mg, containing 20 tablets. The label indicates prescription use only and includes storage instructions to keep at room temperature 20°-25°C (68°-77°F) in a tight, light-resistant container. The product is labeled with NDC 10544-283-20 and manufactured by Blenheim Pharmacal, Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.